Piperidine-MO-1 |
Catalog No.GC31183 |
피페리딘-MO-1은 특허 WO/2005/121087A1, 화합물 실시예 2에서 추출된 도파민 수용체의 조절제이고; 래트 선조체에서 DOPAC 증가 시 68 μmol/kg의 ED50을 나타냅니다.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 871351-61-0
Sample solution is provided at 25 µL, 10mM.
Piperidine-MO-1 is a modulator of dopamine receptor extracted from patent WO/2005/121087A1, compound example 2; exhibits an ED50 of 68 μmol/kg on increase of DOPAC in the rat striatum.
[1]. WO/2005/121087A1
Review for Piperidine-MO-1
Average Rating: 5
(Based on Reviews and 2 reference(s) in Google Scholar.)Review for Piperidine-MO-1
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *